13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0001618205-23-000002
Total Value
$128,033
Positions
55
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 728,585 | $50,498 | 39.54% |
| 2 | BIODESIX INC | BDSX | 5,039,633 | $9,374 | 7.34% |
| 3 | NEUROCRINE BIOSCIENCES INC | NBIX | 84,240 | $8,527 | 6.68% |
| 4 | PROTHENA CORP PLC | PRTA | 128,395 | $6,223 | 4.87% |
| 5 | QUIDELORTHO CORP | QDEL | 61,306 | $5,462 | 4.28% |
| 6 | ACADIA PHARMACEUTICALS INC | ACAD | 249,400 | $4,694 | 3.68% |
| 7 | HARROW HEALTH INC | HROW | 180,000 | $3,809 | 2.98% |
| 8 | UNITED THERAPEUTICS CORP | UTHR | 15,000 | $3,359 | 2.63% |
| 9 | OVINTIV INC | OVV | 84,200 | $3,038 | 2.38% |
| 10 | MASIMO CORP | MASI | 15,280 | $2,820 | 2.21% |
| 11 | PHREESIA INC | PHR | 82,700 | $2,670 | 2.09% |
| 12 | AZIYO BIOLOGICS INC | ELUT | 1,655,184 | $2,499 | 1.96% |
| 13 | FOGHORN THERAPEUTICS INC | FHTX | 264,843 | $1,642 | 1.29% |
| 14 | ACCELERATE DIAGNOSTICS INC | 00430H102 | 2,252,388 | $1,577 | 1.23% |
| 15 | ALKERMES PLC | ALKS | 50,000 | $1,410 | 1.10% |
| 16 | INHIBRX INC | INBX | 70,448 | $1,329 | 1.04% |
| 17 | ALPHATEC HOLDINGS INC | ATEC | 80,000 | $1,248 | 0.98% |
| 18 | KARYOPHARM THERAPEUTICS INC | KPTI | 291,332 | $1,133 | 0.89% |
| 19 | CORCEPT THERAPEUTICS INC | CORT | 50,000 | $1,083 | 0.85% |
| 20 | DOCGO INC | DCGO | 110,000 | $952 | 0.75% |
| 21 | VENTYX BIOSCIENCES INC | 92332V107 | 26,400 | $884 | 0.69% |
| 22 | CYTOKINETICS INC | CYTK | 25,000 | $880 | 0.69% |
| 23 | PROTAGONIST THERAPEUTICS INC | PTGX | 38,000 | $874 | 0.68% |
| 24 | APELLIS PHARMACEUTICALS INC | APLS | 12,000 | $792 | 0.62% |
| 25 | PIONEER NATURAL RESOURCES CO | 723787107 | 3,800 | $776 | 0.61% |
| 26 | EQUITRANS MIDSTREAM CORPORATIO | 294600101 | 133,050 | $769 | 0.60% |
| 27 | TRAVERE THERAPEUTICS INC | TVTX | 30,000 | $675 | 0.53% |
| 28 | BLUEBIRD BIO INC | 09609G100 | 199,200 | $633 | 0.50% |
| 29 | 2SEVENTY BIO INC | 901384107 | 59,833 | $610 | 0.48% |
| 30 | IVERIC BIO INC | 46583P102 | 25,000 | $608 | 0.48% |
| 31 | IMMUNOGEN INC | 45253H101 | 150,000 | $576 | 0.45% |
| 32 | 10X GENOMICS INC | TXG | 10,000 | $558 | 0.44% |
| 33 | SOLENO THERAPEUTICS INC | SLNO | 245,127 | $525 | 0.41% |
| 34 | ARVINAS INC | ARVN | 15,000 | $410 | 0.32% |
| 35 | SILK ROAD MEDICAL INC | 82710M100 | 10,000 | $391 | 0.31% |
| 36 | HALOZYME THERAPEUTICS INC | HALO | 10,000 | $382 | 0.30% |
| 37 | XENON PHARMACEUTICALS INC | XENE | 10,000 | $358 | 0.28% |
| 38 | CHINOOK THERAPEUTICS INC | 16961L106 | 15,000 | $347 | 0.27% |
| 39 | SAREPTA THERAPEUTICS INC | SRPT | 2,500 | $345 | 0.27% |
| 40 | XENCOR INC | XNCR | 12,300 | $343 | 0.27% |
| 41 | KINIKSA PHARMACEUTICALS LTD | KNSA | 30,000 | $323 | 0.25% |
| 42 | KALVISTA PHARMACEUTICALS INC | KALV | 40,000 | $314 | 0.25% |
| 43 | AMICUS THERAPEUTICS INC | FOLD | 28,000 | $311 | 0.24% |
| 44 | KEROS THERAPEUTICS INC | KROS | 7,000 | $299 | 0.23% |
| 45 | PROGYNY INC | PGNY | 9,000 | $289 | 0.23% |
| 46 | CULLINAN ONCOLOGY INC | CGEM | 25,114 | $257 | 0.20% |
| 47 | BIOCRYST PHARMACEUTICALS INC | BCRX | 20,000 | $167 | 0.13% |
| 48 | INFLARX NV | IFRX | 70,000 | $136 | 0.11% |
| 49 | STOKE THERAPEUTICS INC | STOK | 15,000 | $125 | 0.10% |
| 50 | GOSSAMER BIO INC | GOSS | 99,088 | $125 | 0.10% |
| 51 | G1 THERAPEUTICS INC | 3621LQ109 | 40,000 | $107 | 0.08% |
| 52 | NEKTAR THERAPEUTICS | NKTR | 118,000 | $83 | 0.06% |
| 53 | YIELD10 BIOSCIENCE INC | 98585K102 | 18,750 | $52 | 0.04% |
| 54 | ANGION BIOMEDICA CORP | ANGI | 54,392 | $32 | 0.03% |
| 55 | ASPIRA WOMEN'S HEALTH INC | 04537Y109 | 60,070 | $22 | 0.02% |